275 related articles for article (PubMed ID: 27227569)
21. Dual-specificity phosphatase 1 ubiquitination in extracellular signal-regulated kinase-mediated control of growth in human hepatocellular carcinoma.
Calvisi DF; Pinna F; Meloni F; Ladu S; Pellegrino R; Sini M; Daino L; Simile MM; De Miglio MR; Virdis P; Frau M; Tomasi ML; Seddaiu MA; Muroni MR; Feo F; Pascale RM
Cancer Res; 2008 Jun; 68(11):4192-200. PubMed ID: 18519678
[TBL] [Abstract][Full Text] [Related]
22. DUSP1 regulates apoptosis and cell migration, but not the JIP1-protected cytokine response, during Respiratory Syncytial Virus and Sendai Virus infection.
Robitaille AC; Caron E; Zucchini N; Mukawera E; Adam D; Mariani MK; Gélinas A; Fortin A; Brochiero E; Grandvaux N
Sci Rep; 2017 Dec; 7(1):17388. PubMed ID: 29234123
[TBL] [Abstract][Full Text] [Related]
23. DUSP1 induces paclitaxel resistance through the regulation of p-glycoprotein expression in human ovarian cancer cells.
Kang YS; Seok HJ; Jeong EJ; Kim Y; Yun SJ; Min JK; Kim SJ; Kim JS
Biochem Biophys Res Commun; 2016 Sep; 478(1):403-409. PubMed ID: 27422607
[TBL] [Abstract][Full Text] [Related]
24. The role of dual‑specificity phosphatase 1 and protein phosphatase 1 in β2‑adrenergic receptor‑mediated inhibition of extracellular signal regulated kinase 1/2 in triple negative breast cancer cell lines.
Tuglu MM; Bostanabad SY; Ozyon G; Dalkiliç B; Gurdal H
Mol Med Rep; 2018 Jan; 17(1):2033-2043. PubMed ID: 29257221
[TBL] [Abstract][Full Text] [Related]
25. ICER evokes Dusp1-p38 pathway enhancing chemotherapy sensitivity in myeloid leukemia.
Pigazzi M; Manara E; Beghin A; Baron E; Tregnago C; Basso G
Clin Cancer Res; 2011 Feb; 17(4):742-52. PubMed ID: 21325296
[TBL] [Abstract][Full Text] [Related]
26. Adenosine A2A receptor signaling attenuates LPS-induced pro-inflammatory cytokine formation of mouse macrophages by inducing the expression of DUSP1.
Köröskényi K; Kiss B; Szondy Z
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1461-71. PubMed ID: 27066978
[TBL] [Abstract][Full Text] [Related]
27. Parathyroid Hormone-Related Protein Protects Osteoblastic Cells From Oxidative Stress by Activation of MKP1 Phosphatase.
Ardura JA; Portal-Núñez S; Castelbón-Calvo I; Martínez de Toda I; De la Fuente M; Esbrit P
J Cell Physiol; 2017 Apr; 232(4):785-796. PubMed ID: 27357344
[TBL] [Abstract][Full Text] [Related]
28. Dual-specificity phosphatase 1 regulates cell cycle progression and apoptosis in cumulus cells by affecting mitochondrial function, oxidative stress, and autophagy.
Fu XH; Chen CZ; Li S; Han DX; Wang YJ; Yuan B; Gao Y; Zhang JB; Jiang H
Am J Physiol Cell Physiol; 2019 Dec; 317(6):C1183-C1193. PubMed ID: 31532716
[TBL] [Abstract][Full Text] [Related]
29. The expression of dual-specificity phosphatase 1 mRNA is downregulated in lesional psoriatic skin.
Kjellerup RB; Johansen C; Kragballe K; Iversen L
Br J Dermatol; 2013 Feb; 168(2):339-45. PubMed ID: 22924482
[TBL] [Abstract][Full Text] [Related]
30. MKP1 mediates chemosensitizer effects of E1a in response to cisplatin in non-small cell lung carcinoma cells.
Cimas FJ; Callejas-Valera JL; Pascual-Serra R; García-Cano J; Garcia-Gil E; De la Cruz-Morcillo MA; Ortega-Muelas M; Serrano-Oviedo L; Gutkind JS; Sánchez-Prieto R
Oncotarget; 2015 Dec; 6(42):44095-107. PubMed ID: 26689986
[TBL] [Abstract][Full Text] [Related]
31. Dual specificity phosphatase 1 has a protective role in osteoarthritis fibroblast‑like synoviocytes via inhibition of the MAPK signaling pathway.
Peng HZ; Yun Z; Wang W; Ma BA
Mol Med Rep; 2017 Dec; 16(6):8441-8447. PubMed ID: 28983624
[TBL] [Abstract][Full Text] [Related]
32. Effects of silencing the DUSP1 gene using lentiviral vector-mediated siRNA on the release of proinflammatory cytokines through regulation of the MAPK signaling pathway in mice with acute pancreatitis.
Zhang B; Li SL; Xie HL; Fan JW; Gu CW; Kang C; Teng MJ
Int J Mol Med; 2018 Apr; 41(4):2213-2224. PubMed ID: 29393354
[TBL] [Abstract][Full Text] [Related]
33. MKP1 repression is required for the chemosensitizing effects of NF-kappaB and PI3K inhibitors to cisplatin in non-small cell lung cancer.
Cortes-Sempere M; Chattopadhyay S; Rovira A; Rodriguez-Fanjul V; Belda-Iniesta C; Tapia M; Cejas P; Machado-Pinilla R; Manguan-García C; Sánchez-Pérez I; Nistal M; Moratilla C; de Castro-Carpeño J; Gonzalez-Barón M; Albanell J; Perona R
Cancer Lett; 2009 Dec; 286(2):206-16. PubMed ID: 19553005
[TBL] [Abstract][Full Text] [Related]
34. DUSP1 is controlled by p53 during the cellular response to oxidative stress.
Liu YX; Wang J; Guo J; Wu J; Lieberman HB; Yin Y
Mol Cancer Res; 2008 Apr; 6(4):624-33. PubMed ID: 18403641
[TBL] [Abstract][Full Text] [Related]
35. TANK-binding kinase 1 and Janus kinase 2 play important roles in the regulation of mitogen-activated protein kinase phosphatase-1 expression after toll-like receptor 4 activation.
Kim E; Yoon JY; Lee J; Jeong D; Park JG; Hong YH; Kim JH; Aravinthan A; Kim JH; Cho JY
J Cell Physiol; 2018 Nov; 233(11):8790-8801. PubMed ID: 29797567
[TBL] [Abstract][Full Text] [Related]
36. Targeted Inhibition of the Dual Specificity Phosphatases DUSP1 and DUSP6 Suppress MPNST Growth via JNK.
Ramkissoon A; Chaney KE; Milewski D; Williams KB; Williams RL; Choi K; Miller A; Kalin TV; Pressey JG; Szabo S; Azam M; Largaespada DA; Ratner N
Clin Cancer Res; 2019 Jul; 25(13):4117-4127. PubMed ID: 30936125
[TBL] [Abstract][Full Text] [Related]
37. Mitochondrial MKP1 is a target for therapy-resistant HER2-positive breast cancer cells.
Candas D; Lu CL; Fan M; Chuang FY; Sweeney C; Borowsky AD; Li JJ
Cancer Res; 2014 Dec; 74(24):7498-509. PubMed ID: 25377473
[TBL] [Abstract][Full Text] [Related]
38. Impact of DUSP1 on the apoptotic potential of deoxynivalenol in the epithelial cell line HepG2.
Casteel M; Nielsen C; Kothlow S; Dietrich R; Märtlbauer E
Toxicol Lett; 2010 Nov; 199(1):43-50. PubMed ID: 20708668
[TBL] [Abstract][Full Text] [Related]
39. Dual specificity phosphatase 1/CL100 is a direct transcriptional target of E2F-1 in the apoptotic response to oxidative stress.
Wang J; Yin DP; Liu YX; Baer R; Yin Y
Cancer Res; 2007 Jul; 67(14):6737-44. PubMed ID: 17638884
[TBL] [Abstract][Full Text] [Related]
40. Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemia.
Kesarwani M; Kincaid Z; Gomaa A; Huber E; Rohrabaugh S; Siddiqui Z; Bouso MF; Latif T; Xu M; Komurov K; Mulloy JC; Cancelas JA; Grimes HL; Azam M
Nat Med; 2017 Apr; 23(4):472-482. PubMed ID: 28319094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
